BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Arcadia Biosciences Enters Global Collaboration with Arista Cereal Technologies and Bay State Milling Company for Commercialization of High Fiber Wheat

  Arcadia Biosciences, Inc. announced a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling Company for commercialization of its high fiber resistant starch wheat in key wheat markets, including North America, Europe and parts of Asia.

  August 26, 2019

   · 

  6 min read
• Deals

  Maxar Technologies to Attend Upcoming Investor Conferences

  Maxar Technologies, a trusted partner and innovator in Earth Intelligence and Space Infrastructure, announced that members of senior management will present at the following investor conferences:

  August 26, 2019

   · 

  3 min read
• Business

  Fengate welcomes Jaime McKenna as Managing Director and Group Head, Real Estate

  Dividing her time between Fengate’s Toronto and Oakville offices, Jaime leads and is responsible for the firm’s real estate business and is a member of the Executive team.

  August 26, 2019

   · 

  2 min read
• Biotech Beach

  Halozyme To Participate In 2019 Wells Fargo Healthcare Conference

  Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will participate in the 2019 Wells Fargo Healthcare Conference in Boston, MA.

  August 26, 2019

   · 

  1 min read
• Drug Development

  Trovagene Presents Positive Clinical Data from Ongoing Phase 2 Study of Onvansertib in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  Trovagene, Inc. (Nasdaq: TROV), today announced the presentation of positive clinical data from its ongoing Phase 2 clinical trial of onvansertib in combination with Zytiga® (abiraterone acetate)/prednisone

  August 26, 2019

   · 

  8 min read
• Deals

  Audentes Therapeutics to Participate in Upcoming Investor Conferences - Aug. 26, 2019

  Audentes Therapeutics, Inc. announced that it will participate in the following investor conferences in September

  August 26, 2019

   · 

  1 min read
• TerrAscend Receives DTC Eligibility

  TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend” or the “Company”) the first and only cannabis company licensed for sales in Canada, the US, and the EU, today announced it has received approval for Depository Trade Clearance (DTC) settlement services.

  August 26, 2019

   · 

  5 min read
• Deals

  Agilent Completes Acquisition of BioTek Instruments

  Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture and distribution of innovative life science instrumentation.

  August 26, 2019

   · 

  3 min read
• Job Trends

  GT Medical Technologies, Inc. to Be Honored With an AZBio Fast Lane Award

  The Arizona Bioindustry Association (AZBio) today announced that GT Medical Technologies, Inc. (GT MedTech) has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards.

  August 26, 2019

   · 

  6 min read
• BioMidwest

  AtriCure to Participate at the Morgan Stanley 17th Annual Global Healthcare Conference

  AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that the company will be participating in the upcoming Morgan Stanley 17th Annual Global Healthcare Conference in New York City.

  August 26, 2019

   · 

  1 min read